RenovaCare Chairman Invests $15.5 Million to Fund SkinGun Regulatory Submissions and Clinical Trials

Scottsdale, AZ– November 29th, 2018 - RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to over $20 million.

RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal

New York, Pittsburgh & Berlin – January 30, 2018 – RenovaCare, Inc., (OTCQB: RCAR), today highlighted an analysis of treatment results from 44 patients treated for severe second-degree wide-area burn injuries, as published in Burns, the peer-reviewed Journal of the International Society for Burn Injuries. The treatment method, which involved isolating and spraying the patient’s own skin stem cells on to burn wounds, is the technology underlying the RenovaCare patented SkinGun™* and CellMist™ System*.